Ectopic fat storage, insulin resistance, and hypertension.

Abstract:

:Obesity, insulin resistance, glucose intolerance/type 2 diabetes and hypertension are clustered in the metabolic syndrome representing critical risk factors for increased incidence cardio-cerebro-vascular diseases, kidney failure and cancer. Ectopic fat accumulation, i.e., accumulation in the mediastinum, liver and the abdomen, as well as generalized fat accumulation are associated with arterial hypertension, either systolic or diastolic. Several mechanisms including insulin resistance, sub-inflammatory state, increased Renin- Angiotensin-Aldosterone System (RAAS) system activity, oxidative stress, autonomic dysregulation as well as mechanical compression on the kidneys are all activated by obesity. Interestingly angiotensin-converting enzyme (ACE) inhibitors and angiotensin II (ATII) receptor blockers, while correcting arterial hypertension, also have a positive effect on glucose metabolism and diabetes prevention, in high risk patients. The implementation of dietary, medical and surgical strategies to prevent and treat obesity, are cornerstones for the primary prevention as well as treatment of arterial hypertension.

journal_name

Curr Pharm Des

authors

Sironi AM,Sicari R,Folli F,Gastaldelli A

doi

10.2174/138161211798157720

subject

Has Abstract

pub_date

2011-01-01 00:00:00

pages

3074-80

issue

28

eissn

1381-6128

issn

1873-4286

pii

BSP/CPD/E-Pub/000601

journal_volume

17

pub_type

杂志文章,评审
  • Drug discovery of antimicrobial photosensitizers using animal models.

    abstract::Antimicrobial photodynamic therapy (aPDT) is an emerging alternative to antibiotics motivated by growing problems with multi-drug resistant pathogens. aPDT uses non-toxic dyes or photosensitizers (PS) in combination with harmless visible of the correct wavelength to be absorbed by the PS. The excited state PS can form...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211795703735

    authors: Sharma SK,Dai T,Kharkwal GB,Huang YY,Huang L,De Arce VJ,Tegos GP,Hamblin MR

    更新日期:2011-01-01 00:00:00

  • Antiepileptic Treatment Strategy in Vascular Malformations.

    abstract:BACKGROUND:Antiepileptic treatment strategy plays an important role in the management of intracranial vascular malformations. The intracranial vascular malformations can be divided into cavernous hemangiomas, arteriovenous malformations, developmental venous anomalies and capillary telangiectasias. Seizures and hemorrh...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666171027142718

    authors: Giakoumettis D,Margetis K,Stranjalis G,Haliasos N,Papaioannou TG,Themistocleous MS

    更新日期:2017-01-01 00:00:00

  • Identification of HIV inhibitors guided by free energy perturbation calculations.

    abstract::Free energy perturbation (FEP) theory coupled to molecular dynamics (MD) or Monte Carlo (MC) statistical mechanics offers a theoretically precise method for determining the free energy differences of related biological inhibitors. Traditionally requiring extensive computational resources and expertise, it is only rece...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799436421

    authors: Acevedo O,Ambrose Z,Flaherty PT,Aamer H,Jain P,Sambasivarao SV

    更新日期:2012-01-01 00:00:00

  • Novel insights into c-Src.

    abstract::Since identifying a transmissible agent responsible for tumorigenesis in chickens, the v-Src oncogene, significant progress has been made in determining the functions of its cellular homologue. c-Src is the product of the SRC gene and has been found both over-expressed and highly activated in a number of human cancers...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612053507576

    authors: Alper O,Bowden ET

    更新日期:2005-01-01 00:00:00

  • The Lord of the Bacteria: The Fellowship of the Leader and Other Serine Protease Inhibitors.

    abstract::Since antibiotics use is currently limited due to undesired side effects and the increasing antibiotic resistance of various bacteria strains, there is a pressing need to develop new strategies and methods preventing epidemic outbreaks. The virulent potency of bacteria relies on a number of different extracellularly s...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666181219163922

    authors: Burchacka E,Sieńczyk M

    更新日期:2018-01-01 00:00:00

  • Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection.

    abstract::Humans have always lived with tubercle bacilli. Host susceptibility both inherited and acquired determines whether an individual infected with Mycobacterium tuberculosis will eventually fall ill and develop tuberculosis (TB). After infection with M. tuberculosis, a latent TB infection may ensue reflected by immune r...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211797470228

    authors: van Altena R,Duggirala S,Gröschel MI,van der Werf TS

    更新日期:2011-01-01 00:00:00

  • Interactive endogenous small molecule (gaseous) signaling: implications for teratogenesis.

    abstract::Dioxygen (O2) is an exogenously supplied gas with a number of properties that make it valuable as a biological source of energy and as a result much of life has become dependent on this molecule. Nitric oxide (NO), carbon dioxide (CO) and hydrogen sulfide (H2S) are small molecules that are sometimes in a gaseous state...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207782110525

    authors: Fukuto JM,Collins MD

    更新日期:2007-01-01 00:00:00

  • CFTR inhibitors.

    abstract::The cystic fibrosis transmembrane conductance regulator (CFTR) protein is a cAMP-regulated Cl- channel whose major function is to facilitate epithelial fluid secretion. Loss-of-function mutations in CFTR cause the genetic disease cystic fibrosis. CFTR is required for transepithelial fluid transport in certain secretor...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990321

    authors: Verkman AS,Synder D,Tradtrantip L,Thiagarajah JR,Anderson MO

    更新日期:2013-01-01 00:00:00

  • Antioxidant effects of natural bioactive compounds.

    abstract::Reactive oxygen species (ROS), as well as reactive nitrogen species (RNS) play either harmful or beneficial role in biological systems. Beneficial effects of ROS include physiological roles in cellular responses against infectious agents and in several cellular signalling pathways. Harmful effects are due to high conc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209789058084

    authors: Balsano C,Alisi A

    更新日期:2009-01-01 00:00:00

  • Radiolabelled probes targeting infection and inflammation for personalized medicine.

    abstract::Inflammatory and infectious diseases include many different clinical conditions not often well recognised and characterized with conventional radiology and biochemical tests. Radiological techniques (TC, MRI, US) show anatomical changes that usually occur in chronic stages of the disease leading to a delayed diagnosis...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113196660666

    authors: Signore A,Lauri C,Galli F

    更新日期:2014-01-01 00:00:00

  • Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases.

    abstract::Cardiovascular diseases (CVD) are considered a major health problem worldwide, being the main cause of mortality in developing and developed countries. Endothelial dysfunction, characterized by a decline in nitric oxide production and/or bioavailability, increased oxidative stress, decreased prostacyclin levels, and a...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200403172736

    authors: Blanco-Rivero J,Xavier FE

    更新日期:2020-01-01 00:00:00

  • Controlled delivery of peptides and proteins.

    abstract::The final aim/target of Pharmaceutical Sciences is to design successful dosage forms for effective therapy, considering individual patient needs and compliance. Development of new drug entities, particularly using peptides and proteins, is growing in importance and attracting increased interest, as they are specifical...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207779313795

    authors: Degim IT,Celebi N

    更新日期:2007-01-01 00:00:00

  • Drug combinations for dyslipidemia and obesity treatment in metabolic syndrome.

    abstract::Metabolic syndrome (MetS) is a cluster of risk factors, each one individually associated with increased cardiovascular disease risk. Treatment of all components of MetS is expected to result in reduced risk. Treatment of MetS mainly includes lifestyle changes. In addition, drug therapy may be considered, especially co...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209789105054

    authors: Florentin M,Elisaf MS,Mikhailidis DP,Liberopoulos EN

    更新日期:2009-01-01 00:00:00

  • Monocyte as an Emerging Tool for Targeted Drug Delivery: A Review.

    abstract::Monocytes are leading component of the mononuclear phagocytic system that play a key role in phagocytosis and removal of several kinds of microbes from the body. Monocytes are bone marrow precursor cells that stay in the blood for a few days and migrate towards tissues where they differentiate into macrophages. Monocy...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190102104642

    authors: Sabir F,Farooq RK,Asim Ur Rehman,Ahmed N

    更新日期:2018-01-01 00:00:00

  • A Review on Cancer Therapy Based on the Photothermal Effect of Gold Nanorod.

    abstract:BACKGROUND:Cancer causes millions of deaths and huge economic losses every year. The currently practiced methods for cancer therapy have many defects, such as side effects, low curate rate, and discomfort for patients. OBJECTIVE:Herein, we summarize the applications of gold nanorods (AuNRs) in cancer therapy based on ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666191216150052

    authors: Xu W,Lin Q,Yin Y,Xu D,Huang X,Xu B,Wang G

    更新日期:2019-01-01 00:00:00

  • The Emerging Role of Exosomal Non-coding RNAs in Musculoskeletal Diseases.

    abstract::Exosomes are phospholipid bilayer-enclosed membrane vesicles derived and constitutively secreted by various metabolically active cells. They are capable of mediating hetero- and homotypic intercellular communication by transferring multiple cargos from donor cells to recipient cells. Nowadays, non-coding RNAs (ncRNAs)...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666191113104946

    authors: Tu C,He J,Chen R,Li Z

    更新日期:2019-01-01 00:00:00

  • Hypertension - Current Natural Strategies to Lower Blood Pressure.

    abstract::The prevalence of hypertension (HTN) worldwide is high and is constantly rising. HTN is considered to be a silent killer since often there are no obvious symptoms but long-term, HTN significantly increases the risk of coronary heart disease and cerebrovascular diseases. Those with diagnosed HTN or at high risk of its ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170215144649

    authors: Rysz J,Franczyk B,Banach M,Gluba-Brzozka A

    更新日期:2017-01-01 00:00:00

  • Modified polysaccharides as versatile materials in controlled delivery of antidegenerative agents.

    abstract::The mechanisms and factors causing or influencing degenerative diseases require tailor-made solutions. Natural polysaccharides are among the most versatile building units of the novel drug delivery systems. Their properties can be easily tailored to specific needs because they depend not only on the first-order struct...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212800492831

    authors: Karewicz A,Bielska D,Nowakowska M

    更新日期:2012-01-01 00:00:00

  • Microdialysis in neurointensive care.

    abstract::Microdialysis is a technique for sampling the chemistry of the interstitial fluid of tissues and organs in animal and man. It is minimally invasive and simple to perform in a clinical setting. Although microdialysis samples essentially all small molecular substances present in the interstitial fluid the use of microdi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043384105

    authors: Ungerstedt U,Rostami E

    更新日期:2004-01-01 00:00:00

  • Recent Advances in Pharmaceutical Potential of Brown Algal Polysaccharides and their Derivatives.

    abstract::Marine plants, animals and microorganisms display steady growth in the ocean and are abundant carbohydrate resources. Specifically, natural polysaccharides obtained from brown algae have been drawing increasing attention owing to their great potential in pharmaceutical applications. This review describes the structura...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190618143952

    authors: Li J,Cai C,Yang C,Li J,Sun T,Yu G

    更新日期:2019-01-01 00:00:00

  • The cell type-specific signal proteins (pheromones) of protozoan ciliates.

    abstract::In association with their mechanisms of self/non-self recognition (known as mating type systems), ciliates synthesize and constitutively secrete cell type-specific proteins into their extracellular medium. These proteins, designated as pheromones, have been isolated from species of Euplotes and shown to be members of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206777947452

    authors: Luporini P,Vallesi A,Alimenti C,Ortenzi C

    更新日期:2006-01-01 00:00:00

  • Antibodies and their fragments as anti-cancer agents.

    abstract::The recent developments in the field of recombinant DNA, protein engineering and cancer biology, have let us gain insight into many cancer-related mechanisms. Moreover, novel techniques have facilitated tools allowing unique distinction between malignantly transformed cells, to regular ones. This understanding has pav...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206775201983

    authors: Schaedel O,Reiter Y

    更新日期:2006-01-01 00:00:00

  • Naturally Occurring Plectranthus-derived Diterpenes with Antitumoral Activities.

    abstract::The study of natural sources such as plants, microorganisms and marine organisms has developed interest among the scientific community in recent years for their extensive and diverse chemical composition and consequent biological potential. The search for antitumor compounds is among the lead causes that justify phyto...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190115144241

    authors: Garcia C,Teodósio C,Oliveira C,Oliveira C,Díaz-Lanza A,Reis C,Duarte N,Rijo P

    更新日期:2018-01-01 00:00:00

  • Animal models to study plaque vulnerability.

    abstract::The need to identify and characterize vulnerable atherosclerotic lesions in humans has lead to the development of various animal models of plaque vulnerability. In this review, current concepts of the vulnerable plaque as it leads to an acute coronary event are described, such as plaque rupture, erosion, intraplaque h...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207780487575

    authors: Schapira K,Heeneman S,Daemen MJ

    更新日期:2007-01-01 00:00:00

  • Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy.

    abstract::By updating John Littleton's work published 15 years ago this review summarizes recent work on pharmacodynamic aspects of acamprosate and the perspective for future developments. In addition to insights into the role of glutamatergic receptor systems, craving and relapse inspired by acamprosate, clinical research poin...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210791516341

    authors: Kiefer F,Mann K

    更新日期:2010-01-01 00:00:00

  • LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics.

    abstract::Over the past decade, Lymphocyte Function-Associated Antigen-1 (LFA-1, alphaLbeta2, CD11a/CD18) has emerged as an attractive therapeutic target for the treatment of multiple inflammatory diseases. Its established role in the trafficking and activation of leukocytes coupled with the recent elucidation of the global con...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206777947731

    authors: Giblin PA,Lemieux RM

    更新日期:2006-01-01 00:00:00

  • Selective inhibitors of zinc-dependent histone deacetylases. Therapeutic targets relevant to cancer.

    abstract::Histone deacetylases (HDACs), which act on acetylated histones and/or other non-histone protein substrates, represent validated epigenetic targets for the treatment of cancer and other human diseases. The inhibition of HDAC activity was shown to induce cell cycle arrest, differentiation, apoptosis as well as a decreas...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666141110164604

    authors: Kollar J,Frecer V

    更新日期:2015-01-01 00:00:00

  • Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment.

    abstract::The last decades have witnessed an explosion in studies of the role of amyloid-β (Aβ) in the progress of the neurodegenerative disorder Alzheimer's disease (AD) and it is now widely accepted that Aβ is related to the pathogenesis of AD. For example, studies have shown that Aβ is neurotoxic and that the neurotoxicity o...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211797416039

    authors: Portelius E,Mattsson N,Andreasson U,Blennow K,Zetterberg H

    更新日期:2011-01-01 00:00:00

  • Rheumatology: a force for change in monoclonal antibodies.

    abstract::Monoclonal antibodies have undergone a radical evolutionary journey over the last 25 years, with advances in molecular biology, process development and drug formulation underpinning their rise to becoming one of the most efficacious and economically important class of drug today. The success of antibodies for the trea...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150310142202

    authors: Lowe DC,Vaughan TJ

    更新日期:2015-01-01 00:00:00

  • Heme Oxygenase and the Skin in Health and Disease.

    abstract::The skin is often introduced as the largest organ of the human body which - being uniquely exposed to external stress - faces several types of challenges, from physical, chemical, biological, and immunological origin. Therefore, the skin is also a site where inflammation, oxidative stress and cellular damage occurs re...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180717155953

    authors: Szabo IL,Kenyeres A,Szegedi A,Szollosi AG

    更新日期:2018-01-01 00:00:00